COVID-19 vaccine vial maker Stevanato preps IPO valuing it at up to $5 billion: sources – Reuters

LONDON (Reuters) – Italys Stevanato Group, manufacturer of glass vials for COVID-19 vaccines and other healthcare products, is making plans for an initial public offering this year that could value t… [read more]

Leave a Comment